Negócios · 15/03/20111 min de leitura
Investigational New Drug Applications and Abbreviated New Drug Applications; Technical Amendment
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is amending its investigational new drug application (IND) regulations and abbreviated new drug application regulations to correct inaccurate cross-references to the IND regulations and the Federal Food, Drug, and Cosmetic Act (the FD&C Act). This action is being taken to ensure accuracy and clarity in the Agency's regulations.